Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gioia Chengcheng Sha
MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
mTORC1 Inhibition Is Required for Sensitivity to PI3K P110 Inhibitors in PIK3CA-Mutant Breast Cancer
Science Translational Medicine
Medicine
Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia
Clinical Cancer Research
Cancer Research
Oncology
Substrate-Selective COX-2 Inhibition as a Novel Strategy for Therapeutic Endocannabinoid Augmentation
Trends in Pharmacological Sciences
Toxicology
Pharmacology
DDR1 Inhibition as a New Therapeutic Strategy for Colorectal Cancer
Molecular and Cellular Oncology
Cancer Research
Molecular Medicine
Inhibition of the BCR-Abl Tyrosine Kinase as a Therapeutic Strategy for CML
Oncogene
Cancer Research
Genetics
Molecular Biology
RAD001 Offers a Therapeutic Intervention Through Inhibition of mTOR as a Potential Strategy for Esophageal Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Inhibition of 12/15-Lipoxygenase as Therapeutic Strategy to Treat Stroke
Annals of Neurology
Neurology
Combined PPARg Activation and XIAP Inhibition as a Potential Therapeutic Strategy for Ovarian Granulosa Cell Tumors
Molecular Cancer Therapeutics
Cancer Research
Oncology
A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution
Cell Reports
Biochemistry
Genetics
Molecular Biology